Aon researchers found that within two years, improved health outcomes for patients who were taking GLP-1 drugs lowers the growth rate of medical care costs. Aon looked at medical claims data for ...
People with diabetes and others taking glucagon-like peptide-1 receptor agonists (GLP-1RAs) should be monitored for nutritional deficiencies and muscle loss, researchers said. "We found that adults ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results